MedTrace Logo

Lung Disease Collection (Qatar): Evaluation of the Lungs of Individuals With Lung Disease

NCT00504738 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2015-04-21

No results posted yet for this study

Summary

The purpose of this protocol is to obtain biologic samples from the blood and lungs from patients with lung diseases in order to study the causes and indications of these disorders, learn how these lung disease manifest and progress, and how the lung disease can be treated.

Conditions

Sponsors & Collaborators

  • Weill Cornell Medical College in Qatar

    collaborator OTHER

  • Hamad Medical Corporation

    collaborator INDUSTRY

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Ronald G. Crystal, MD · Weill Cornell Medical College, New York and Qatar

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Completion
2007-04-30

Countries

  • Qatar

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00504738 on ClinicalTrials.gov